Drug intelligence / Profile preview

Dermatophagoides pteronyssinus antigen-antibody complexes

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
Administration
Intradermal
01

Overview

Dermatophagoides pteronyssinus antigen-antibody complexes are laboratory-prepared immune complexes formed by combining purified allergens from the house dust mite *Dermatophagoides pteronyssinus* with an excess of autologous specific antibodies (typically IgG or IgE) derived from allergic patients. These complexes have been investigated as a therapeutic intervention for patients with chronic bronchial asthma who are hypersensitive to *D. pteronyssinus*. The proposed mechanism involves intradermal inoculation of these pre-formed immune complexes, which leads to a marked reduction in clinical symptoms and medication use in allergic individuals. The treatment is associated with decreased specific skin and bronchial reactivity and significant reductions in serum levels of allergen-specific IgE antibodies, suggesting modulation of the allergic response distinct from conventional hyposensitization (allergen immunotherapy). No systemic side effects were observed in clinical studies; only mild local reactions occurred at injection sites[1]. This approach is experimental and not widely used or approved as standard therapy.

Other names
Dpt antigen-antibody complexeshouse dust mite antigen-antibody complexesDermatophagoides pteronyssinus immune complex
02

Targets

FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)IgE (Immunoglobulin E)Der p 1 (Dermatophagoides pteronyssinus allergen 1)Dermatophagoides farinae major allergen Der f 1

Beyond the preview

Go deeper on Dermatophagoides pteronyssinus antigen-antibody complexes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermatophagoides pteronyssinus antigen-antibody complexes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call